Related Experiment Video
Updated: Sep 19, 2025
11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
19.5K
MFDSMC: Accurate Identification of Cancer-Driver Synonymous Mutations Using Multiperspective Feature Representation
Lihua Wang1,2, Chen Ye1, Na Cheng3
1Information Materials and Intelligent Sensing Laboratory of Anhui Province, Institutes of Physical Science and Information Technology, Anhui University, Hefei, Anhui 230601, China.
Journal of Chemical Information and Modeling
|June 6, 2025
Summary
We developed a computational tool, MFDSMC, to accurately identify cancer-driving synonymous mutations. This predictor integrates multiple biological features to distinguish driver mutations from neutral ones, aiding cancer research.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Synonymous mutations, despite not altering amino acid sequences, can drive cancer through various molecular mechanisms.
- Distinguishing driver synonymous mutations from passenger mutations is crucial for understanding tumorigenesis.
Purpose of the Study:
- To develop a computational framework, MFDSMC, for improved prediction of human cancer-driver synonymous mutations.
- To integrate diverse biological features for enhanced predictive accuracy.
Main Methods:
- Curated synonymous mutations from public databases.
- Characterized features across sequence context, evolutionary conservation, epigenetic modifications, and regulatory/functional predictions.
- Utilized machine learning, specifically XGBoost, after feature selection and evaluation.
Main Results:
- The multiperspective fusion model significantly outperformed single-perspective models.
- Epigenetic and regulatory/functional features notably improved prediction performance.
- MFDSMC demonstrated superior performance on independent test sets compared to existing methods.
Conclusions:
- MFDSMC offers a novel and precise solution for predicting cancer-driver synonymous mutations.
- The framework has potential applications in genomic research and clinical settings.
- Accurate identification of driver synonymous mutations is critical for cancer studies.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.1K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
01:33Cancer-Critical Genes I: Proto-oncogenes
9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K